MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NAUT had $2,238K increase in cash & cash equivalents over the period. -$13,610K in free cash flow.

Cash Flow Overview

Change in Cash
$2,238K
Free Cash flow
-$13,610K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of secu...
    • Stock-based compensation
    • Amortization of operating lease ...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of securities
    • Operating lease liabilities
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-14,697 -13,781 -13,574 -31,646
Stock-based compensation
1,362 1,471 1,496 3,877
Amortization of operating lease right-of-use assets
1,142 1,183 1,193 2,336
Depreciation
-1,753 --
In-process research and development
-0 --
Depreciation
-1,014 -426 922
Amortization (accretion) of premiums (discounts) on securities, net
68 134 306 980
Prepaid expenses and other assets
355 -395 11 -160
Accounts payable
200 2 -20 -51
Accrued expenses and other liabilities
128 -703 942 390
Operating lease liabilities
-1,146 -1,213 -1,180 -2,295
Net cash used in operating activities
-13,100 -12,375 -11,034 -27,287
Proceeds from maturities of securities
25,805 34,750 28,363 45,878
Purchases of securities
11,062 33,719 27,493 11,278
Purchases of property and equipment
510 244 418 615
Cash paid in connection with asset acquisition
-0 --
Net cash provided by investing activities
14,233 787 452 33,985
Proceeds from issuance of common stock under employee stock purchase plan
-69 0 87
Proceeds from exercise of stock options
1,105 32 0 26
Net cash provided by financing activities
1,105 101 0 113
Net increase in cash, cash equivalents and restricted cash
2,238 -11,487 -10,582 6,811
Cash, cash equivalents and restricted cash at beginning of period
13,390 24,877 28,648 -
Cash, cash equivalents and restricted cash at end of period
15,628 13,390 24,877 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof securities$25,805K Proceeds from exercise ofstock options$1,105K Net cash provided byinvesting activities$14,233K Net cash provided byfinancing activities$1,105K Canceled cashflow$11,572K Net increase incash, cash...$2,238K Canceled cashflow$13,100K Purchases of securities$11,062K Purchases of property andequipment$510K Stock-based compensation$1,362K something is missing$1,348K Amortization of operatinglease right-of-use...$1,142K Accounts payable$200K Accrued expenses andother liabilities$128K Net cash used inoperating activities-$13,100K Canceled cashflow$4,180K Net loss-$14,697K Operating leaseliabilities-$1,146K Depreciation-$1,014K Prepaid expenses andother assets$355K Amortization (accretion) ofpremiums (discounts) on...$68K

Nautilus Biotechnology, Inc. (NAUT)

Nautilus Biotechnology, Inc. (NAUT)